LOEROP JAMES (Chief Business Officer) reported 1 transaction at ACLARIS THERAPEUTICS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 2/3/2026ACC: 0001781549-26-000007
Officer· Chief Business Officer
Since Jan 2022
-15.98K
Net shares
Net seller
$39.6K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
15.98K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−15.98K
Price / share
$2.48
Trade value
$39.63K
% of position
13.5%
2/1/2025
118.75K→102.77K
Total
Net shares
−15.98K
Net value
-$39.63K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/1/2025 | F · Tax Withholding | −15.98K | $2.48 | $39.63K | 13.5% | 118.75K | 102.77K |
| Total | −15.98K | -$39.63K | ||||||
Derivative Transactions0
No derivative transactions reported